The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
Open accessAbstract
BACKGROUND: A number of US observational studies reported an increased mortality risk with higher intact parathyroid hormone (iPTH), calcium and/or phosphate. The existence of such a link in a European haemodialysis population was explored as part of the Analysing Data, Recognising Excellence and Optimising Outcomes (ARO) Chronic Kidney Disease (CKD) Research Initiative. METHODS: The association between the markers of mineral and bone disease and clinical outcomes was examined in 7970 patients treated in European Fresenius Medical Care facilities over a median of 21 months. Baseline and time-dependent (TD) Cox regression were performed using Kidney Disease Outcomes Quality Initiative (KDOQI) target ranges as reference categories, adjusting for demographics, medical history, dialysis parameters, inflammation, medications and laboratory parameters. Fractional polynomial (FP) models were also used. RESULTS: Hazard ratio (HR) estimates from baseline analysis for iPTH were U-shaped [>600 pg/mL, HR = 2.10, 95% confidence interval (CI) 1.62-2.73; <75 pg/mL, HR = 1.46, 95% CI 1.17-1.83]. TD analysis confirmed the results for iPTH. Baseline analysis showed that calcium >2.75 mmol/L increased risk of death (HR = 1.70, 95% CI 1.19-2.42). TD analysis showed that both low (HR = 1.19, 95% CI 1.04-1.37) and high calcium (HR = 1.74, 95% CI 1.30-2.34) increased risk of death. Baseline analysis for phosphate showed a U-shaped pattern (<1.13 mmol/L, HR = 1.18, 95% CI 1.01-1.37; >1.78 mmol/L, HR = 1.32, 95% CI 1.13-1.55). TD analysis confirmed the results for phosphate <1.13 mmol/L. HR estimates were higher in patients with diabetes versus those without diabetes for baseline analysis only (P-value = 0.014). FP analysis confirmed the results of baseline and TD analyses. CONCLUSION: Patients with iPTH, calcium and phosphate levels within the KDOQI target ranges have the lowest risk of mortality compared with those outside the target ranges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
Endocrine regulation of energy metabolism by the skeleton
Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.047 · Cited by 2,554 · cited 1×
“Interestingly, transgenic mouse models also show that low serum osteocalcin levels, as observed in adynamic bone disease, are a cause of glucose intolerance and insulin resistance, highlighting the possibility that adynamic bone disease may exacerbate diabetes [32].”
BackgroundSelf-citationK/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Massry, S. G., Coburn, J. W., Chertow, G. M., Hruska, K. A., Langman, C. B., Malluche, H. H., Martin, K. J., McCann, L. M., McCarthy, J. T., Moe, S. M., et al. (2003) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2,527
Block, G., Hulbert-Shearon, T., Levin, N., & Port, F. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531176 · Cited by 2,354
MacLeod, A. M. (2009) · Kidney International · Cited by 2,219
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
(2003) · PubMed · Cited by 1,372
Sauerbrei, W., Royston, P., & Binder, H. (2007) · Statistics in Medicine · doi:10.1002/sim.3148 · Cited by 1,171
Tentori, F., Blayney, M. J., Albert, J. M., Gillespie, B. W., Kerr, P. G., Bommer, J., Young, E. W., Akizawa, T., Akiba, T., Pisoni, R. L., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.03.020 · Cited by 1,075
Kalantar-Zadeh, K., Kuwae, N., Regidor, D. L., Kovesdy, C. P., Kilpatrick, R. D., Shinaberger, C. S., McAllister, C. J., Budoff, M. J., Salusky, I. B., & Kopple, J. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001514 · Cited by 905
Block, G. A., Raggi, P., Bellasi, A., Kooienga, L., & Spiegel, D. M. (2007) · Kidney International · doi:10.1038/sj.ki.5002059 · Cited by 796
Goodkin, D. A., Bragg-Gresham, J. L., Koenig, K. G., Wolfe, R. A., Akiba, T., Andreucci, V. E., Saito, A., Rayner, H. C., Kurokawa, K., Port, F. K., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000100127.54107.57 · Cited by 761
Young, E. W., Albert, J. M., Satayathum, S., Goodkin, D. A., Pisoni, R. L., Akiba, T., Akizawa, T., Kurokawa, K., Bommer, J., Piera, L., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00185.x · Cited by 753
Inflammation, Malnutrition, and Cardiac Disease as Predictors of Mortality in Hemodialysis Patients
Qureshi, A. R., Alvestrand, A., Divino-Filho, J. A. A. C., Gutierrez, A., Heimbu[Combining Diaeresis]rger, O., Lindholm, B., & Bergstro[Combining Diaeresis]m, J. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v13suppl_1s28 · Cited by 488
Wang, A. Y.-M., Wang, M., Woo, J., Lam, C. W.-K., Li, P. K.-T., Lui, S.-F., & Sanderson, J. E. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000038685.95946.83 · Cited by 394
Stevens, L. A., Djurdjev, O., Cardew, S., Cameron, E. C., & Levin, A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113243.24155.2f · Cited by 354
Association of Bone Activity, Calcium Load, Aortic Stiffness, and Calcifications in ESRD
London, G. A. A. M., Marchais, S. J., Gue[Combining Acute Accent]rin, A. P., Boutouyrie, P., Me[Combining Acute Accent]tivier, F., & de Vernejoul, M.-C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050622 · Cited by 296
Inter-method variability in PTH measurement: Implication for the care of CKD patients
Souberbielle, J.-C., Boutten, A., Carlier, M.-C., Chevenne, D., Coumaros, G., Lawson-Body, E., Massart, C., Monge, M., Myara, J., Parent, X., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5001606 · Cited by 290
de Mutsert, R., Grootendorst, D. C., Indemans, F., Boeschoten, E. W., Krediet, R. T., & Dekker, F. W. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2008.08.003 · Cited by 274
Sauerbrei, W., & Royston, P. (2005) · Methods of Information in Medicine · doi:10.1055/s-0038-1634008 · Cited by 198
Vascular calcification and renal osteodystrophy relationship in chronic kidney disease
Moe, S. M. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01665.x · Cited by 149
Lacson, E., Wang, W., Hakim, R. M., Teng, M. F., & Lazarus, J. M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.07.031 · Cited by 134
Effects of high concentrations of glucose on PTH secretion in parathyroid cells
Sugimoto, T., Ritter, C. S., Morrissey, J. J., Hayes, C., & Slatopolsky, E. (1990) · Kidney International · doi:10.1038/ki.1990.144 · Cited by 118
Low Bone Volume—A Risk Factor for Coronary Calcifications in Hemodialysis Patients
Adragão, T., Herberth, J., Monier‐Faugere, M., Branscum, A. J., Ferreira, A., Frazão, J. M., Curto, J. D., & Malluche, H. H. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01870408 · Cited by 113
Wald, R., Sarnak, M. J., Tighiouart, H., Cheung, A. K., Levey, A. S., Eknoyan, G., & Miskulin, D. C. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.05.020 · Cited by 110
The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?
Malluche, H. H. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1002 · Cited by 81
Cited by
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses
Vandenberg, L. N., Colborn, T., Hayes, T. B., Heindel, J. J., Jacobs, D. R., Lee, D.-H., Shioda, T., Soto, A. M., vom Saal, F. S., Welshons, W. V., et al. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1050 · Cited by 3,209
KDOQI clinical practice guideline for nutrition in CKD: 2020 update
Ikizler, T. A., Burrowes, J. D., Byham-Gray, L. D., Campbell, K. L., Carrero, J.-J., Chan, W., Fouque, D., Friedman, A. N., Ghaddar, S., Goldstein-Fuchs, D. J., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.05.006 · Cited by 1,960
(2017) · Kidney International Supplements · doi:10.1016/j.kisu.2017.04.001 · Cited by 1,956
Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
The EVOLVE Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205624 · Cited by 971
Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder
Fukagawa, M., Yokoyama, K., Koiwa, F., Taniguchi, M., Shoji, T., Kazama, J. J., Komaba, H., Ando, R., Kakuta, T., Fujii, H., et al. (2013) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12058 · Cited by 402
Metadata
- Authors
- Floege, J., Kim, J., Ireland, E., Chazot, C., Drueke, T., de Francisco, A., Kronenberg, F., Marcelli, D., Passlick-Deetjen, J., Schernthaner, G., Fouqueray, B., Wheeler, D. C., & on behalf of the ARO Investigators
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-25
- Volume
- 26
- Issue
- 6
- Pages
- 1948-1955
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2138829372
- Cited by
- 477
- References
- 25
- FWCI
- 18.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.